SCHEMBL13955447

SCHEMBL13955447

FC(F)(F)Oc1ccc(Nc2ncc(CCc3cccnc3)c3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 8/20 0.56
▸ BCR P11274 8/20 0.56
▸ EPHX2 P34913 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ CTSC P53634 1/20 0.44
▸ FLT1 P17948 4/20 0.44
▸ KDR P35968 3/20 0.44
▸ DHODH Q02127 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ TTBK1 Q5TCY1 1/20 0.42
▸ TTBK2 Q6IQ55 1/20 0.42
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ SCN5A Q14524 1/20 0.41
▸ SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13955414 0.86 PLK1 (0.46) ABL1BCREPHX2RAB9AFLT1
SCHEMBL1382926 0.84 FLT1 (0.46) FLT1KDRCYP3A4
SCHEMBL1382851 0.82 FLT1 (0.60) FLT1KDR
SCHEMBL1386339 0.82 KDR (0.48) NPC1RAB9AFLT1KDR
SCHEMBL1383504 0.81 KDR (0.44) FLT1KDRCYP3A4CYP2C9CYP2C19
SCHEMBL1386811 0.81 KDR (0.44) CTSCFLT1KDR
SCHEMBL1387032 0.80 KDR (0.54) FLT1KDR
SCHEMBL1383042 0.79 KIF11 (0.53) CTSCFLT1KDRDHODHCYP3A4
SCHEMBL1385235 0.77 NAMPT (0.46) NPC1CTSCFLT1KDR
SCHEMBL1383724 0.77 KDR (0.53) CTSCFLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603566-B1 USE OF ISOQUINOLINE DERIVATIVES FOR TREATING CANCER AND MAP KINASE RELATED DISEASES NOVARTIS AG (CH) 2009-01-21 — — EP disclosed
Send feedback